z-logo
open-access-imgOpen Access
ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden
Author(s) -
A.E. Bochem,
Diederik F. van Wijk,
Adriaan G. Holleboom,
Raphaël Duivenvoorden,
M. Mahdi Motazacker,
Geesje M. DallingaThie,
E. de Groot,
John J.P. Kastelein,
Aart J. Nederveen,
G. Kees Hovingh,
E.S.G. Stroes
Publication year - 2012
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1093/eurheartj/ehs376
Subject(s) - medicine , abca1 , body mass index , cardiology , cholesterol , diabetes mellitus , endocrinology , high density lipoprotein , risk factor , transporter , gene , genetics , biology
Low HDL-C is a potent risk factor for cardiovascular disease (CVD). Yet, mutations in ABCA1, a major determinant of circulating HDL-C levels, were previously not associated with CVD risk in cohort studies. To study the consequences of low plasma levels of high-density lipoprotein cholesterol (HDL-C) due to ATP-binding cassette transporter A1 (ABCA1) dysfunction for atherosclerotic vascular disease in the carotid arteries.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom